Thiopurine long term remission rates: is the glass half empty?

The place of thiopurines as first line therapy for IBD should be reviewed because a high proportion of patients discontinue them due to either relapse or side effects, Canadian researchers say Their study of 148 patients (100 with Crohn’s Disease, 48 with ulcerative colitis) found that fewer than one in four (23%) remained on them ...

Already a member?

Login to keep reading.

© 2021 the limbic